A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients
Articolo
Data di Pubblicazione:
2020
Abstract:
This study was an open-label, 2-arms, monocentric, randomized clinical trial comparing Xonrid®, a topical medical device, versus standard of care (SOC) in preventing and treating acute radiation dermatitis (ARD) in Head and Neck Cancer (HNC) and Breast Cancer (BC) patients undergoing radiotherapy (RT).
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Acute radiation dermatitis; Breast cancer; Head and neck cancer; Patient-reported outcome measures; Quality of life; Skin toxicity; Skindex-16; Xonrid®
Elenco autori:
Ingargiola, Rossana; De Santis, Maria Carmen; Iacovelli, Nicola Alessandro; Facchinetti, Nadia; Cavallo, Anna; Ivaldi, Eliana; Dispinzieri, Michela; Franceschini, Marzia; Giandini, Carlotta; Romanello, Domenico Attilio; Di Biaso, Simona; Sabetti, Michela; Locati, Laura; Alfieri, Salvatore; Bossi, Paolo; Guglielmo, Mauro; Macchi, Fabio; Lozza, Laura; Valdagni, Riccardo; Fallai, Carlo; Pignoli, Emanuele; Orlandi, Ester
Link alla scheda completa:
Pubblicato in: